Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$20.34
0.452.26%
At close: -
$20.34
0.000.00%
After Hours: 4:01 PM EDT
Comments
Loading...
MediWound Analyst Ratings and Price Targets | NASDAQ:MDWD | Benzinga
MediWound Ltd has a consensus price target of $31.2 based on the ratings of 5 analysts. The high is $39 issued by Craig-Hallum on February 28, 2025. The low is $25 issued by Cowen & Co. on December 30, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co., HC Wainwright & Co., and Craig-Hallum on May 22, 2025, March 20, 2025, and February 28, 2025, respectively. With an average price target of $31.67 between HC Wainwright & Co., HC Wainwright & Co., and Craig-Hallum, there's an implied 55.69% upside for MediWound Ltd from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Craig-Hallum
Oppenheimer
Cowen & Co.
Maxim Group
1calculated from analyst ratings
Analyst Ratings for MediWound
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/22/2025 | Buy Now | 52.41% | HC Wainwright & Co. | Swayampakula Ramakanth38% | $25 → $31 | Maintains | Buy | Get Alert |
| 03/20/2025 | Buy Now | 22.91% | HC Wainwright & Co. | Swayampakula Ramakanth38% | $25 → $25 | Reiterates | Buy → Buy | Get Alert |
| 02/28/2025 | Buy Now | 91.74% | Craig-Hallum | Chase Knickerbocker62% | → $39 | Initiates | → Buy | Get Alert |
| 01/10/2025 | Buy Now | 22.91% | HC Wainwright & Co. | Swayampakula Ramakanth38% | $25 → $25 | Reiterates | Buy → Buy | Get Alert |
| 11/27/2024 | Buy Now | 22.91% | HC Wainwright & Co. | Swayampakula Ramakanth38% | $28 → $25 | Maintains | Buy | Get Alert |
| 10/11/2024 | Buy Now | 37.66% | HC Wainwright & Co. | Swayampakula Ramakanth38% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 08/15/2024 | Buy Now | 37.66% | HC Wainwright & Co. | Swayampakula Ramakanth38% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 07/16/2024 | Buy Now | 37.66% | HC Wainwright & Co. | Swayampakula Ramakanth38% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 05/30/2024 | Buy Now | 37.66% | HC Wainwright & Co. | Swayampakula Ramakanth38% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 03/22/2024 | Buy Now | 37.66% | HC Wainwright & Co. | Swayampakula Ramakanth38% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 01/16/2024 | Buy Now | 37.66% | HC Wainwright & Co. | Swayampakula Ramakanth38% | $26 → $28 | Maintains | Buy | Get Alert |
| 11/22/2023 | Buy Now | 27.83% | HC Wainwright & Co. | Swayampakula Ramakanth38% | → $26 | Reiterates | Buy → Buy | Get Alert |
| 09/21/2023 | Buy Now | 27.83% | HC Wainwright & Co. | Swayampakula Ramakanth38% | $23 → $26 | Maintains | Buy | Get Alert |
| 08/17/2023 | Buy Now | 76.99% | Oppenheimer | Francois Brisebois41% | $63 → $36 | Maintains | Outperform | Get Alert |
| 08/17/2023 | Buy Now | 13.08% | HC Wainwright & Co. | Swayampakula Ramakanth38% | → $23 | Reiterates | Buy → Buy | Get Alert |
| 05/31/2023 | Buy Now | 209.73% | Oppenheimer | Francois Brisebois41% | → $63 | Reiterates | Outperform → Outperform | Get Alert |
| 05/31/2023 | Buy Now | 13.08% | HC Wainwright & Co. | Swayampakula Ramakanth38% | → $23 | Reiterates | Buy → Buy | Get Alert |
| 03/17/2023 | Buy Now | 13.08% | HC Wainwright & Co. | Swayampakula Ramakanth38% | → $23 | Reiterates | → Buy | Get Alert |
| 01/04/2023 | Buy Now | 13.08% | HC Wainwright & Co. | Swayampakula Ramakanth38% | $5.5 → $23 | Maintains | Buy | Get Alert |
| 12/30/2022 | Buy Now | 22.91% | Cowen & Co. | Joshua Jennings56% | $6 → $25 | Maintains | Outperform | Get Alert |
| 12/22/2022 | Buy Now | 22.91% | Maxim Group | Michael Okunewitch27% | → $25 | Initiates | → Buy | Get Alert |
| 12/21/2022 | Buy Now | 209.73% | Oppenheimer | Francois Brisebois41% | $9 → $63 | Maintains | Outperform | Get Alert |
| 11/16/2022 | Buy Now | -72.96% | HC Wainwright & Co. | Swayampakula Ramakanth38% | $6 → $5.5 | Maintains | Buy | Get Alert |
| 07/18/2022 | Buy Now | -65.59% | Oppenheimer | Francois Brisebois41% | → $7 | Assumes | → Outperform | Get Alert |
FAQ
What is the target price for MediWound (MDWD) stock?
The latest price target for MediWound (NASDAQ:MDWD) was reported by HC Wainwright & Co. on May 22, 2025. The analyst firm set a price target for $31.00 expecting MDWD to rise to within 12 months (a possible 52.41% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for MediWound (MDWD)?
The latest analyst rating for MediWound (NASDAQ:MDWD) was provided by HC Wainwright & Co., and MediWound maintained their buy rating.
When was the last upgrade for MediWound (MDWD)?
There is no last upgrade for MediWound
When was the last downgrade for MediWound (MDWD)?
There is no last downgrade for MediWound.
When is the next analyst rating going to be posted or updated for MediWound (MDWD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MediWound, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MediWound was filed on May 22, 2025 so you should expect the next rating to be made available sometime around May 22, 2026.
Is the Analyst Rating MediWound (MDWD) correct?
While ratings are subjective and will change, the latest MediWound (MDWD) rating was a maintained with a price target of $25.00 to $31.00. The current price MediWound (MDWD) is trading at is $20.34, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
